YEMESRACH MENGESHA: Open Payments
NPI 1932569068 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 60 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $159 · 2025 $1,011
Food & beverage: $1,011
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $253 |
| ABBVIE INC. | 14 | $209 |
| Collegium Pharmaceutical, Inc. | 12 | $194 |
| Lundbeck LLC | 6 | $136 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $74 |
| PFIZER INC. | 2 | $40 |
| Biogen, Inc. | 1 | $34 |
| Globus Medical, Inc. | 1 | $26 |
| Electronic Waveform Lab, Inc. | 1 | $23 |
| Averitas Pharma Inc. | 1 | $23 |
Products named: RELISTOR, Belbuca, VYEPTI, UBRELVY, JOURNAVX, BOTOX, QULIPTA, NURTEC ODT.
Industry payments across MD — which companies pay providers there.
